Home › NDC Lookup › Ingredients › Acetaminophen And Chlorpheniramine Malea... › 72030-0002-01
Ganmaoling Acetaminophen and Chlorpheniramine Maleate 60 mg; .667 mg Tablet, 120-count — NDC 72030-0002-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Ganmaoling Acetaminophen and Chlorpheniramine Maleate 60 mg; .667 mg Tablet, 120-count — NDC 72030-002-01 (Billing 72030-0002-01)

by ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD. · 1 BOTTLE in 1 BOX / 120 TABLET in 1 BOTTLE

This is a package of 120 tablets of Ganmaoling Acetaminophen and Chlorpheniramine Maleate 60 mg; .667 mg Tablet from ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD., marketed since Nov 2018 and currently FDA-listed, this package's marketing is listed to end Aug 2029. It is this product's only package size.

NDC 72030-0002-01
🏷️ FDA NDC (as labeled) 72030-002-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 72030-002-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
72030 labeler · 002 product · 01 package
Package marketed since
Nov 26, 2018
Package marketing ended
Aug 30, 2029
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 7203000201 0
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 72030-002-01
Product NDC 72030-002
11-digit billing NDC 72030000201
RxCUI 1599133
UNII 362O9ITL9D, V1Q0O9OJ9Z
Application # M012
SPL Set ID c757a03e-59ea-469c-970d-4bc62e73f36f
Established class (EPC) Histamine-1 Receptor Antagonist
Mechanism of action Histamine H1 Receptor Antagonists
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-11-26
Marketing end 2029-08-30
Route ORAL
Dosage form TABLET
Substance ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE
Quick answers
  • RxCUI (RxNorm): 1599133
Why two NDCs? The FDA registers this code as 72030-002-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72030-0002-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Anilides class.

Drug family (ATC) Anilides
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 About the active ingredient: Acetaminophen; Chlorpheniramine Maleate MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.

Acetaminophen is used to relieve mild to moderate pain and to reduce fever. Acetaminophen is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers). It works by changing the way the body senses pain and by cooling the body.

Read the full MedlinePlus article ↗
🧪 What is this product?

Ganmaoling is an over-the-counter oral tablet containing acetaminophen and chlorpheniramine maleate. Acetaminophen is commonly used to reduce fever and relieve minor aches and pain. Chlorpheniramine maleate is an antihistamine typically used to reduce allergy symptoms such as sneezing, itching, and runny nose. This combination product represents an OTC monograph drug marketed under FDA category guidelines for this class of medication.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
72030-0002-01 You're viewing this Main listing 1 BOTTLE in 1 BOX / 120 TABLET in 1 BOTTLE 2018-11-26 Aug 30, 2029 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Yinchiao 60 mg/1; .667 mg 72030-0001-01 ANHUI 120 tablets — — FDA listed —
Ganmaoling 60 mg/1; .667 mgthis 72030-0002-01 ANHUI 120 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2018
On the market since
Nov 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color yellow
ShapeRound
ImprintGM
Size10 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII I6OER6U04L
    A plant extract from chrysanthemum flowers used as a natural colorant and flavoring agent in medicines. It may contribute mild taste or visual appeal to the final product.
  • UNII I753WB2F1M
    FD&C Yellow No. 5 is a synthetic yellow colorant approved by the FDA. It is added to medicines to make pills, tablets, or liquids visually distinct and easier to identify.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII S7K9P1V8VG
    A plant-derived ingredient from the roots of Ilex asprella (a type of holly). It acts as a natural filler and may help bind ingredients together in the formulation.
  • UNII 4465L2WS4Y
    A plant extract from Japanese honeysuckle flowers used as a natural flavoring and fragrance ingredient in medicines. It may also help preserve the product and add pleasant taste or aroma.
  • UNII Z400593S4G
    A plant extract from the root of Melicope pteleifolia, a tree native to Asia. It may serve as a flavoring agent, fragrance component, or natural extract to add taste or aroma to the medicine.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII F1919HP06B
    A plant-derived substance from the Strobilanthes cusia root, traditionally used in herbal medicine. In medications, it may serve as a natural colorant, binder, or active botanical ingredient depending on the formulation.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
  • UNII C92PGK11XB
    Vitex negundo whole is a plant material from the chaste tree used in traditional medicine formulations. In modern medicines, it may serve as a natural extract or botanical ingredient to support the overall formulation's intended properties.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients Rough-leaved holly root, evodia root, wild chrysanthemum flower, Chinese chaste tree twig, honeysuckle flower, strobilanthes cusia root, cornstarch, sucrose, water, FD&C yellow no.5 and FD&C yellow no.6.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD.
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code72030
First marketedNov 2018
Product typeHuman Otc Drug
Portfolio3 products on file

More NDCs from ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD. labeler code 72030

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 40 words ▾

Uses Temporarily relieves the following symptoms associated with the common cold, hay fever, or other upper respiratory allergies: minor aches and pains headache muscular aches fever sore throat sneezing itching of the nose or throat runny nose itchy, watery eyes

⏱️ Dosage and Administration 53 words ▾

Directions adults and children 12 years of age and older: Take 6 tablets every 4 hours, not more than 36 tablets in 24 hours children 6 to under 12 years of age: Take 3 tablets every 4 hours, not more than 18 tablets in 24 hours children under 6 years: consult a doctor

⚠️ Warnings 1 words ▾

Warnings

📦 Storage and Handling 15 words ▾

Other information protect from light our excessive heat keep tightly closed keep in dry place

🧪 Active Ingredient 12 words ▾

Active ingredient (in each tablet) Acetaminophen 60 mg Chlorpheniramine maleate 0.667 mg

🧪 Inactive Ingredients 29 words ▾

Inactive ingredients Rough-leaved holly root, evodia root, wild chrysanthemum flower, Chinese chaste tree twig, honeysuckle flower, strobilanthes cusia root, cornstarch, sucrose, water, FD&C yellow no.5 and FD&C yellow no.6.

🎯 Purpose 5 words ▾

Purpose Pain reliever-fever reducer Antihistamine

📄 Do Not Use 17 words ▾

Do not use for pain for more than 10 days for fever for more than 3 days

📄 Ask a Doctor Before Use If 29 words ▾

Ask a doctor before use if the user has glaucoma a breathing problem such as emphysema or chronic bronchitis difficulty in urination due to enlargement of the prostate gland

📄 Ask a Doctor or Pharmacist Before Use If 14 words ▾

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers

📄 When Using This Product 35 words ▾

When using this product may cause excitability especially in children may cause drowsiness (alcohol, sedatives, and tranquilizers may increase the drowsiness effect) avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery

📄 Stop Use and Ask a Doctor If 41 words ▾

Stop use and ask a doctor if pain or fever persists or worsen new symptoms occur redness or swelling is present sore throat: is severe last for more than 2 days is accompanied or followed by: fever headache rash nausea vomiting

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 43 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

📄 Questions or Comments 29 words ▾

Questions or Comments? (888) 221-3496 M-F 9 am to 5 pm you may also use this number to report serious adverse events associated with the use of this product

📄 Package Label / Principal Display Panel 11 words ▾

GANMAOLING TABLETS, NDC 72030-002-01, Antihistamine, Pain Reliever-Fever Reducer, 120 Tablets Box1.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for GANMAOLING (this brand).

Top reported reactions

Agranulocytosis1
Chapped Lips1
Chest Discomfort1
Chromaturia1
Condition Aggravated1
Drug-induced Liver Injury1
Dry Skin1

Reporter sex

5 reports
Male · 25%
Female · 75%

Serious outcomes

Hospitalization5
Reports over time (by year) — tap or hover for the count & year
2024 2025 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD. has reported a marketing end date of 2029-08-30, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 72030-0001-01 · ANHUI 72030-0100-01 · ANHUI →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.